US – Data, insights and consulting company Kantar has collaborated with Komodo Health to link clinical encounter and patient reported outcomes (PRO) data to improve patient outcomes.

The partnership will give data-driven artificial intelligence (AI) tools to life science companies to reduce the burden of disease and improve outcomes. It supports Kantar’s new Claritis offer, which links PRO and clinical data.

Claritis supports scenarios including: evidence to support reimbursement decisions; supporting regulatory bodies that need proof of real-world safety and effectiveness; and generating critical information for other healthcare stakeholders such as healthcare professionals, patients and caregivers.

Komodo Health’s AI platform cross-links patient data with other medical and healthcare datasets to extract new insights and deliver predictive analytics. It’s Healthcare Map connects more than 50bn clinical encounters in a de-identified and compliant way. It’s used to better understand disease burden, identify patient cohorts of interest, predict disease progression and improve standards of care.

Jeremy Brody, chief strategy officer for Kantar’s health division said: "Through its rich clinical encounter data, Komodo Health has assembled an impressive, comprehensive picture of patient journeys across the US healthcare system. Its Healthcare Map links over 150 payer-complete datasets, providing real-time and longitudinal data on more than 300m US patients. This partnership will deliver major advancements in evidence generation for real world research."